Clinical Trial Update: EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases

View source ↗

Summary

A planned clinical trial uses endoscopic ultrasound-guided circulating tumor cells combined with multi-omics to predict recurrence and metastasis in pancreatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Resectable Pancreatic Cancer
• Liver Metastases
• Pancreatic Cancer
• Resectable Pancreatic Cancer

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: CTCs, Pancreatic Cancer | Status: NOT_YET_RECRUITING